Edition:
United Kingdom

Acceleron Pharma Inc (XLRN.OQ)

XLRN.OQ on NASDAQ Stock Exchange Global Market

46.58USD
20 Jul 2018
Change (% chg)

$0.28 (+0.60%)
Prev Close
$46.30
Open
$46.29
Day's High
$46.70
Day's Low
$45.38
Volume
95,756
Avg. Vol
126,848
52-wk High
$50.00
52-wk Low
$30.62

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 3.23 -0.576
FY 2017 Dec '17 3.70 -0.617
Sep '17 3.01 -0.647
Jun '17 3.06 -0.768
Mar '17 3.70 -0.662
FY 2016 Dec '16 3.37 -0.509
Sep '16 3.01 -0.552
Jun '16 3.19 -0.591
Mar '16 18.20 0.131
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 10 6.77 27.88 2.70 4.18
Quarter Ending Dec-18 10 10.63 28.74 2.40 4.18
Year Ending Dec-18 12 25.02 42.00 12.10 34.10
Year Ending Dec-19 13 65.70 170.19 17.40 107.33
Earnings (per share)
Quarter Ending Sep-18 13 -0.62 -0.18 -0.83 -0.71
Quarter Ending Dec-18 13 -0.58 -0.07 -0.95 -0.74
Year Ending Dec-18 13 -2.42 -1.82 -3.10 -2.16
Year Ending Dec-19 14 -1.90 -0.30 -3.48 -1.01
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.33 32.76
P/E High - Last 5 Yrs. -- 298.33 45.44
P/E Low - Last 5 Yrs. -- 91.43 24.26
Beta 1.66 0.93 0.89
Price to Sales (TTM) 127.91 112.52 5.73
Price to Book (MRQ) 7.82 15.54 5.47
Price to Tangible Book (MRQ) 8.91 14.64 7.05
Price to Cash Flow (TTM) -- 72.59 23.29
% Owned Institutions 82.71 14.53 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.35 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -4.32 408.02 8.01
Sales (TTM) vs TTM 1 Yr. Ago -55.25 79.88 5.64
Sales - 5 Yr. Growth Rate -19.25 32.06 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -30.02 29.02 20.60
EPS (TTM) vs TTM 1 Yr. Ago -55.59 -- --
EPS - 5 Yr. Growth Rate -- 39.49 10.66
Capital Spending - 5 Yr. Growth Rate 162.73 39.97 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 10.38 5.50 3.03
LT Debt to Equity (MRQ) 0.00 34.92 12.51
Total Debt to Equity (MRQ) 0.00 36.72 16.84
Interest Coverage (TTM) -- -101.16 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.68 54.37
Gross Margin - 5 Yr. Avg. -- 50.98 52.17
EBITD Margin (TTM) -731.42 -- --
EBITD - 5 Yr. Avg -145.29 -586.56 10.81
Operating Margin (TTM) -748.05 -733.21 4.58
Operating Margin - 5 Yr. Avg. -153.69 -608.15 6.23
Pre-Tax Margin (TTM) -723.96 -707.36 5.43
Pre-Tax Margin - 5 Yr. Avg. -170.41 -611.67 6.67
Net Profit Margin (TTM) -724.23 -708.75 1.73
Net Profit Margin - 5 Yr. Avg. -170.43 -614.69 2.94
Effective Tax Rate (TTM) -- 23.23 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.56 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 108,562 23,025,841 860,394,083
Net Income/Employee (TTM) -786,240 3,117,868 101,209,433
Receivable Turnover (TTM) 4.29 20.74 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.05 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.42 0.27 11.14
Return on Assets - 5 Yr. Avg. -34.02 3.72 12.40
Return on Investment (TTM) -41.85 2.22 14.61
Return on Investment - 5 Yr. Avg. -40.72 2.89 16.14
Return on Equity (TTM) -44.00 3.86 16.34
Return on Equity - 5 Yr. Avg. -939.02 3.83 17.40
  1 Year 3 Year 5 Year
Sales % 53.46 -21.42 -19.25
EPS (TTM) % 20.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Acceleron Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 90.28%
# of Holders: 225
Total Shares Held: 41,326,772
3 Mo. Net Change: 56,568
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 12
# Reduced Positions: 9
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.